These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 5364983

  • 1. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T, Annaka S, Baba T, Kanno M.
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H, Keresztes L, Stenzel K.
    Minerva Med; 1968 Dec 12; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N, Haţegan D.
    Rev Roum Neurol; 1973 Dec 12; 10(6):531-7. PubMed ID: 4771091
    [No Abstract] [Full Text] [Related]

  • 5. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A, Sluga E, Moser K.
    Wien Klin Wochenschr; 1971 Feb 19; 83(7):109-13. PubMed ID: 5547427
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G, Lapi AS, Schwarzenberg TL, Canibus R, Natoli V.
    Arch Ital Pediatr Pueric; 1968 Feb 19; 26(1):36-46. PubMed ID: 5737311
    [No Abstract] [Full Text] [Related]

  • 8. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A, Leone P, Moretti A.
    Clin Pediatr (Bologna); 1967 Sep 19; 49(9):468-75. PubMed ID: 5608288
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Biochemistry of myopathies].
    Heyck H, Laudahn G.
    Hippokrates; 1967 Dec 15; 38(23):909-22. PubMed ID: 4891060
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
    Niebrój-Dobosz I, Jedrzejowska H, Hetnarska L.
    Acta Med Pol; 1970 Dec 15; 11(4):387-93. PubMed ID: 5493781
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum enzyme alterations in neuromuscular disorders.
    Munsat TL, Baloh R, Pearson CM, Fowler W.
    JAMA; 1973 Dec 24; 226(13):1536-43. PubMed ID: 4800933
    [No Abstract] [Full Text] [Related]

  • 15. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A, Leone P.
    Clin Pediatr (Bologna); 1967 May 24; 49(5):237-45. PubMed ID: 6080497
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
    Yamaji K, Imai H, Esaki K, Tokoro T, Hotta K.
    Nagoya Med J; 1968 Apr 24; 14(1):55-64. PubMed ID: 5696330
    [No Abstract] [Full Text] [Related]

  • 19. [Changes in the activity of blood serum enzymes in relatives of children with myopathy].
    Grinio LP.
    Vopr Med Khim; 1966 Apr 24; 12(6):600-3. PubMed ID: 6000902
    [No Abstract] [Full Text] [Related]

  • 20. Inflammatory myopathy with facioscapulohumeral distribution.
    Munsat TL, Piper D, Cancilla P, Mednick J.
    Neurology; 1972 Apr 24; 22(4):335-47. PubMed ID: 5062826
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.